Episode 557: AI-Powered Rapid Disease Detection: How LightAI is Transforming Healthcare Diagnostics

Over 600 million people suffer from viral and bacterial infections each year—but what if AI could change that? LightAI Inc. (CBOE CA: ALGO | FSE: 0HC) is tackling antimicrobial resistance with its AI-powered diagnostic tool, capable of distinguishing between viral and bacterial infections using just a smartphone image. This breakthrough technology has the potential to reduce unnecessary antibiotic use and expand access to rapid, cost-effective healthcare worldwide. Join us for an exclusive interview with CEO Peter Whitehead as he shares how LightAI is transforming disease detection, its progress toward regulatory approvals, and their vision for global expansion into key markets. Investors won’t want to miss this discussion on a game-changing innovation in AI-driven healthcare. Learn more about LightAI: https://light.ai/ Watch the full YouTube interview here: https://youtu.be/A6LbwaXIVrw And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1